Repurposed drugs may halt the spread of cancer cells

July 11, 2018 by Melanie Cross, Tulane University
Asim Abdel-Mageed, DVM, PhD, Zimmerman Professor of Cancer Research at Tulane University School of Medicine, and his colleagues were part of a team that published their research in 'Scientific Reports' this spring. The research examined whether drugs already approved to treat other diseases or conditions could be effective in blocking the spread of cancer cells. Credit: Tulane Cancer Center

For cancer cells to spread to other places in the body—or metastasize—they need to communicate with one another. One way they do this is through chemical messages delivered in exosomes, the molecules that carry information from cell to cell.

Currently there are no known drugs that selectively target and inhibit the production and release of exosomes by tumor cells.

This spring, Asim Abdel-Mageed, DVM, PhD, Zimmerman Professor of Cancer Research at Tulane University School of Medicine, and his colleagues published their research that examined whether drugs already approved to treat other diseases or conditions could be effective in blocking the activity of exosomes. Their work was published in Scientific Reports.

In partnership with investigators at the National Center for Advancing Translational Science and with the support of a $4.2 million NIH grant awarded in 2014, Abdel-Mageed and his collaborators investigated 4,580 known pharmacologically active compounds and FDA-approved drugs using a rapid, high-volume, robotic screening technique. Twenty-two — including antibiotics, antifungal medicines and anti-inflammatory agents — were effective in preventing advanced prostate tumor from releasing exosomes or in blocking their production.

"Exosomes are routinely biosynthesized and released by , including prostate , and are implicated in cancer progression," Abdel-Mageed said.

"Because discovery from concept to market takes an average time of 12 years, our identified drugs could be repurposed for the treatment of advanced prostate cancer within a relatively short period of time." In fact, combining the repurposed drugs with conventional therapy was promising in reducing tumor burden in a pre-clinical animal model of cancer. Of course, much work remains to determine which individual drugs or combinations might be useful in patients.

Further research into this approach could also be useful in treating other advanced cancers, as well as diseases such as Alzheimer's.

Abdel-Mageed worked with Tulane collaborators Debasis Mondal, PhD, and Raju Thomas, MD, who he said were instrumental not only in the original grant application, but also in data and outcomes analysis.

Explore further: Researchers uncover new target to stop cancer growth

More information: Amrita Datta et al. High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: A drug repurposing strategy for advanced cancer, Scientific Reports (2018). DOI: 10.1038/s41598-018-26411-7

Related Stories

Researchers uncover new target to stop cancer growth

June 21, 2018
Researchers at the University of Wisconsin-Madison have discovered that a protein called Munc13-4 helps cancer cells secrete large numbers of exosomes—tiny, membrane-bound packages containing proteins and RNAs that stimulate ...

When one drug fails, a new door opens for cancer treatment

June 26, 2018
A new class of cancer drugs—called CDK4/6 inhibitors—recently approved to treat breast cancer can stunt the cancer's growth and replication. It is also being explored for a number of other cancers. Unfortunately, patients ...

Metastasizing cancer cells modify bone remodeling with small RNA secretion

March 26, 2018
Prostate cancer is one of the most common cancers in men worldwide. In nearly three out of four patients, the cancer causes metastasis, leaving the original site of the tumor and spreading to distant sites throughout the ...

Recommended for you

Researchers identify a mechanism that fuels cancer cells' growth

November 14, 2018
Scientists at the UCLA Jonsson Comprehensive Cancer Center have identified sodium glucose transporter 2, or SGLT2, as a mechanism that lung cancer cells can utilize to obtain glucose, which is key to their survival and promotes ...

A new approach to detecting cancer earlier from blood tests: study

November 14, 2018
Cancer scientists led by principal investigator Dr. Daniel De Carvalho at Princess Margaret Cancer Centre have combined "liquid biopsy", epigenetic alterations and machine learning to develop a blood test to detect and classify ...

New antibody breakthrough to lead the fight against cancer

November 14, 2018
Scientists at the University of Southampton have developed a new antibody that could hold the key to unlocking cancer's defence against the body's immune system.

Photoacoustic imaging may help doctors detect ovarian tumors earlier

November 14, 2018
Ovarian cancer claims the lives of more than 14,000 in the U.S. each year, ranking fifth among cancer deaths in women. A multidisciplinary team at Washington University in St. Louis has found an innovative way to use sound ...

Solving the mystery of NPM1 in acute myeloid leukemia

November 13, 2018
Although it has long been recognized that mutations of gene NPM1 play an important role in acute myeloid leukemia, no one has determined how the normal and the mutated forms of the protein NPM1 function.

Cognitive decline—radiation—brain tumor prevented by temporarily shutting down immune response

November 13, 2018
Treating brain tumors comes at a steep cost, especially for children. More than half of patients who endure radiation therapy for these tumors experience irreversible cognitive decline, a side-effect that has particularly ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.